Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) Director James T. Treace acquired 50,000 shares of Treace Medical Concepts stock in a transaction dated Tuesday, May 28th. The stock was purchased at an average price of $5.07 per share, with a total value of $253,500.00. Following the completion of the purchase, the director now […]
Peregrine Capital Management LLC bought a new position in Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) during the first quarter, according to its most recent disclosure with the SEC. The institutional investor bought 280,178 shares of the company’s stock, valued at approximately $7,058,000. Peregrine Capital Management LLC owned 0.46% of Treace Medical Concepts at […]
Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Rating) saw a large decrease in short interest during the month of April. As of April 30th, there was short interest totalling 1,290,000 shares, a decrease of 25.9% from the April 15th total of 1,740,000 shares. Currently, 3.1% of the company’s shares are short sold. Based on an […]
Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Rating) was the recipient of a significant decrease in short interest during the month of April. As of April 30th, there was short interest totalling 1,290,000 shares, a decrease of 25.9% from the April 15th total of 1,740,000 shares. Currently, 3.1% of the shares of the stock are […]
Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Rating) Director James T. Treace sold 10,000 shares of the stock in a transaction that occurred on Monday, May 1st. The shares were sold at an average price of $25.24, for a total value of $252,400.00. Following the transaction, the director now directly owns 861,441 shares of the […]